Open AccessContinuous Intravenous Infusion of Bumetanide to Achieve Diuresis in Patients with Congestive Heart Failure and Chronic Kidney Disease: A Rapid Review
Author(s) -
Deepak Goyal
Publication year - 2021
Publication title -
nephrology and renal therapy
Language(s) - English
Resource type - Journals
ISSN - 2473-7313
DOI - 10.24966/nrt-7313/100045
Subject(s) - bumetanide , furosemide , diuresis , medicine , heart failure , kidney disease , diuretic , loop diuretic , intensive care medicine , kidney , cotransporter , chemistry , organic chemistry , sodium
Bumetanide falls in the class of loop diuretics like furosemide. The effects of both have been extensively researched and are well documented. In medical practice furosemide is more widely used in patients both orally and through intravenous administration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom